Drs. Kristen Scarpato, David Ambinder Discuss Salvage Therapy Options for BCR Prostate Cancer
By Kristen Scarpato, MD, MPH, David Ambinder, MD - May 1, 2023At an American Urological Association plenary session, a panel of experts debated salvage therapy options after RT failure for a patient with biochemically recurrent (BCR) prostate cancer. The panel weighed the pros and cons of surgery, cryotherapy, high intensity focused ultrasound, and ADT/observation.
David Ambinder, MD, New York Medical College/Westchester Medical Center, interviewed panelist Kristen Scarpato, MD, MPH, Vanderbilt University Medical Center, on when focal therapy and other treatment options should be recommended in this patient population.
View more AUA 2023 meeting coverage.
Related Posts
One might assume that the AUA meeting is geared toward practicing urologists, but it is also crucial for urologic trainees.
Drs. David Ambinder and Akhil Saji highlight the importance of attending the AUA meeting as urology residents.
Researchers found 18F-rhPSMA-7.3 to have a high affinity and potential for low bladder activity.
Dr. Wallis interviews Dr. Luckenbaugh on the important research coming out of the AUA meeting pertaining to kidney cancer.
The relevant updates to the guideline for upper tract urothelial carcinoma are provided by Dr. Peter Clark.
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.